XBiotech Inc. (XBIT) |
|
15.06 -1.47 (-8.89%)
|
02-14 16:00 |
|
Open: |
16.66 |
Pre. Close: |
16.53 |
|
High:
|
16.89 |
Low:
|
14.73 |
|
Volume:
|
1,278,218 |
Market Cap:
|
564M |
|
|
|
|
XBiotech Inc is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
16.923 - 17.019 |
17.019 - 17.123 |
|
Low:
|
14.489 - 14.584 |
14.584 - 14.688 |
|
Close:
|
14.878 - 15.046 |
15.046 - 15.228 |
|
Technical analysis |
as of: 2020-02-14 4:33:53 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 25.63  One year: 30.84 |
| Support: |
Support1: 14.73 Support2: 12.26 |
| Resistance: |
Resistance1: 21.94 Resistance2: 26.40 |
| Pivot: |
21.35 |
| Moving Average: |
MA(5): 19.41 MA(20): 21.81
MA(100): 15.33  MA(250): 11.30 |
| MACD: |
MACD(12,26): -0.45 Signal(9): 0.46 |
| Stochastic oscillator: |
%K(14,3): 11.87 %D(3): 15.50 |
| RSI: |
RSI(14): 22.41 |
| 52-week: |
High: 26.40 Low: 6.76 Change(%): 75.3 |
| Average Vol(K): |
3-Month: 85715 10-Days: 131018 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.XBIT has closed below the lower band by 19.9%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 67.9% wider than normal. The large width of the bands suggest high volatility as compared to XBIT's normal range. The bands have been in this wide range for 0 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
2020-02-11
XBiotech : Initial filing by director officer or owner of more than ten percent. | MarketScreener
SEC Form 3 … | February 11, 2020
2020-01-15
The Daily Biotech Pulse: Nektar Withdraws Opioid Pain Drug NDA, Galapagos Takes Stake In Fibrocor, Integra Lifesciences Lowers Q4 Guidance
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on Jan. 14.) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP ): announced an oncology stem cell therapy pact with Astellas Pharma Inc. (OTC: ALPMY ). Applied Therapeutics Inc (NASDAQ: APLT ) Arvinas Inc (NASDAQ: ARVN ) AtriCure Inc. (NASDAQ: ATRC ) AVITA MED LTD/S ADR (NASDAQ: RCEL ) Biondvax Pharmaceuticals Ltd – ADR (NASDAQ: BVXV ) Calithera Biosciences Inc (NASDAQ: CALA ) Editas Medicine Inc (NASDAQ: EDIT ) Eli Lilly And Co (NYSE: LLY ) Epizyme Inc (NASDAQ: EPZM ) Fate Therapeutics Inc (NASDAQ: FATE ) Frequency Therapeutics Inc (NASDAQ: FREQ ) Halozyme Therapeutics, Inc. (NASDAQ: HALO ) (provided 2020 guidance) Hologic, Inc. (NASDAQ: HOLX ) Medpace Holdings Inc (NASDAQ: MEDP ) Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA ) Myokardia Inc (NASDAQ: MYOK ) NeoGenomics, Inc. (NASDAQ: NEO ) Novo Nordisk A/S (NYSE: NVO ) NuVasive, Inc. (NASDAQ: NUVA ) Profound Medical Corp (NASDAQ: PROF ) Repligen Corporation (NASDAQ: RGEN ) Replimune Group Inc (NASDAQ: REPL ) Revance Therapeutics Inc (NASDAQ: RVNC ) Syneos Health, Inc. (NASDAQ: SYNH ) TG Therapeutics Inc common stock (NASDAQ: TGTX ) Varian Medical Systems, Inc. (NYSE: VAR ) Viela Bio Inc (NASDAQ: VIE ) West Pharmaceutical Services Inc. (NYSE: WST ) XBiotech Inc (NASDAQ: XBIT ) (announced a tender offer to buy up to $420 million worth …
|
Financial Analysis |
| Growth |
NA |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
NA |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
NA |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
NA |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: Nasdaq Global Select |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
41.09 |
| Shares Float (M) |
25.44 |
|
% Held by Insiders
|
39.54 |
|
% Held by Institutions
|
24.99 |
|
Shares Short (K)
|
3240 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-0.640 |
|
Book Value (p.s.)
|
1.570 |
|
PEG Ratio
|
|
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
-25.9 |
|
Return on Equity (ttm)
|
-43.0 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
-0.526 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-19.64 |
|
Levered Free Cash Flow (M)
|
-10.88 |
Stock Valuations |
|
P/E
|
-23.53 |
|
P/E Growth Ratio
|
-0.09 |
|
P/BV
|
9.59 |
|
P/S
|
|
|
P/CF
|
-31.51 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
|
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
